Our technology, opens completely new and exciting opportunities in the eye care for the relief and prevention of ophthalmological diseases in various indications for patients.
Our team of seasoned industry experts explores the world of water-free therapies to develop best-in-class ocular therapies. We expand into other eye care indications and topical therapeutics spaces.
Our late-stage investigational drug developments provide unique therapeutic options for millions of diagnosed but untreated or undertreated dry eye patients:
Novaliq is a private biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the worldwide first water-free ophthalmic technology.
